Accumulation of M1-like macrophages in type 2 diabetic islets is followed by a systemic shift in macrophage polarization

Journal of Leukocyte Biology

Volumn 95, Issue 1, 2014, Pages 149-160

  Cucak, Helena ^a   Grunnet, Lars Groth ^a   Rosendahl, Alexander ^a  

^a HAGEDORN RESEARCH INSTITUTE   (Denmark)

Author keywords

Cytokines; Inflammation; Insulin

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD68 ANTIGEN; CD86 ANTIGEN; COLONY STIMULATING FACTOR 1; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; GALECTIN 3; GLUCOSE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CD68 ANTIGEN, HUMAN; CYTOKINE; DIFFERENTIATION ANTIGEN; INSULIN; LEUKOCYTE ANTIGEN; MONOCYTE MACROPHAGE DIFFERENTIATION ANTIGEN; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL INVASION; CELL ISOLATION; CELL POPULATION; CELL SIZE; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; INNATE IMMUNITY; MACROPHAGE ACCUMULATION; MACROPHAGE FUNCTION; MACROPHAGE POLARIZATION; MACROPHAGE SUBPOPULATION; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET CELL; PHENOTYPE; PRIORITY JOURNAL; SPLEEN; SYSTEMIC DISEASE; ANIMAL; BIOSYNTHESIS; DISEASE COURSE; DISEASE MODEL; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; INFLAMMATION; MACROPHAGE; METABOLISM; PATHOLOGY;

CYTOKINES; INFLAMMATION; INSULIN;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BLOOD GLUCOSE; CYTOKINES; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; IMMUNOPHENOTYPING; INFLAMMATION MEDIATORS; INSULIN; ISLETS OF LANGERHANS; MACROPHAGES; MALE; MICE; PHENOTYPE;

EID: 84897019577     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0213075     Document Type: Article

References (48)

1. Chen, L., Magliano, D. J., Zimmet, P. Z. (2012) The worldwide epidemiology of type 2 diabetes mellitus, present and future perspectives. Nat. Rev. Endocrinol. 8, 228-236.
2. Kahn, S. E., Hull, R. L., Utzschneider, K. M. (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840-846.
3. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., Ferrante, A. W. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808.
4. Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R. L., Ferrante A. W., Jr., (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116, 115-124.
5. Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., Butler, P. C. (2003) β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52, 102-110.
6. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
7. Stout, R. D., Jiang, C., Matta, B., Tietzel, I., Watkins, S. K., Suttles, J. (2005) Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175, 342-349.
8. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686.
9. Pillai, M. M., Hayes, B., Torok-Storb, B. (2009) Inducible transgenes under the control of the hCD68 promoter identifies mouse macrophages with a distribution that differs from the F4/80-and CSF-1R-expressing populations. Exp. Hematol. 37, 1387-1392.
10. Gordon, S., Mantovani, A. (2011) Diversity and plasticity of mononuclear phagocytes. Eur. J. Immunol. 41, 2470-2472.
11. Balbo, P., Silvestri, M., Rossi, G. A., Crimi, E., Burastero, S. E. (2001) Differential role of CD80 and CD86 on alveolar macrophages in the presentation of allergen to T lymphocytes in asthma. Clin. Exp. Allergy 31, 625-636.
12. Neels, J. G., Olefsky, J. M. (2006) Inflamed fat: what starts the fire? J. Clin. Invest. 116, 33-35.
13. Zeyda, M., Stulnig, T. M. (2007) Adipose tissue macrophages. Immunol. Lett. 112, 61-67.
14. Lumeng, C. N., Bodzin, J. L., Saltiel, A. R. (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184.
15. Fujisaka, S., Usui, I., Bukhari, A., Ikutani, M., Oya, T., Kanatani, Y., Tsuneyama, K., Nagai, Y., Takatsu, K., Urakaze, M., Kobayashi, M., Tobe, K. (2009) Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 58, 2574-2582.
16. Ehses, J. A., Perren, A., Eppler, E., Ribaux, P., Pospisilik, J. A., Maor-Cahn, R., Gueripel, X., Ellingsgaard, H., Schneider, M. K., Biollaz, G., Fontana, A., Reinecke, M., Homo-Delarche, F., Donath, M. Y. (2007) Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56, 2356-2370.
17. Richardson, S., Willcox, A., Bone, A., Foulis, A., Morgan, N. (2009) Isletassociated macrophages in type 2 diabetes. Diabetologia 52, 1686-1688.
18. Agudo, J., Ayuso, E., Jimenez, V., Casellas, A., Mallol, C., Salavert, A., Tafuro, S., Obach, M., Ruzo, A., Moya, M., Pujol, A., Bosch, F. (2012) Vascular endothelial growth factor-mediated islet hypervascularization and inflammation contribute to progressive reduction of β-cell mass. Diabetes 61, 2851-2861.
19. Eguchi, K., Manabe, I., Oishi-Tanaka, Y., Ohsugi, M., Kono, N., Ogata, F., Yagi, N., Ohto, U., Kimoto, M., Miyake, K., Tobe, K., Arai, H., Kadowaki, T., Nagai, R. (2012) Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation. Cell. Metab. 15, 518-533.
20. Wellen, K. E., Hotamisligil, G. S. (2005) Inflammation, stress, and diabetes. J. Clin. Invest. 115, 1111-1119.
21. Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., Donath, M. Y. (2007) Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517-1526.
22. Böni-Schnetzler, M., Boller, S., Debray, S., Bouzakri, K., Meier, D. T., Prazak, R., Kerr-Conte, J., Pattou, F., Ehses, J. A., Schuit, F. C., Donath, M. Y. (2009) Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology 150, 5218-5229.
23. Westwell-Roper, C., Dai, D. L., Soukhatcheva, G., Potter, K. J., van Rooijen, N., Ehses, J. A., Verchere, C. B. (2011) IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J. Immunol. 187, 2755-2765.
24. Bendtzen, K., Mandrup-Poulsen, T., Nerup, J., Nielsen, J., Dinarello, C., Svenson, M. (1986) Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 232, 1545-1547.
25. Coleman, D. L. (1982) Diabetes-obesity syndromes in mice. Diabetes 31 (Suppl. 1), 1-6.
26. Kawasaki, F., Matsuda, M., Kanda, Y., Inoue, H., Kaku, K. (2005) Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice. Am. J. Physiol. Endocrinol. Metab. 288, E510-E518.
27. Orland, M. J., Permutt, M. A. (1987) Quantitative analysis of pancreatic proinsulin mRNA in genetically diabetic (db/db) mice. Diabetes 36, 341-347.
28. Saksida, T., Nikolic, I., Vujicic, M., Nilsson, U. J., Leffler, H., Lukic, M. L., Stojanovic, I., Stosic-Grujicic, S. (2013) Galectin-3 deficiency protects pancreatic islet cells from cytokine-triggered apoptosis in vitro. J. Cell. Physiol. 228, 1568-1576.
29. Song, L., Lee, C., Schindler, C. (2011) Deletion of the murine scavenger receptor CD68. J. Lipid Res. 52, 1542-1550.
30. Chung, A. W., Sieling, P. A., Schenk, M., Teles, R. M., Krutzik, S. R., Hsu, D. K., Liu, F. T., Sarno, E. N., Rea, T. H., Stenger, S., Modlin, R. L., Lee, D. J. (2013) Galectin-3 regulates the innate immune response of human monocytes. J. Infect. Dis. 207, 947-956.
31. Hsu, D. K., Yang, R-Y., Pan, Z., Yu, L., Salomon, D. R., Fung-Leung, W-P., Liu, F-T. (2000) Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am. J. Pathol. 156, 1073-1083.
32. MacKinnon, A. C., Farnworth, S. L., Hodkinson, P. S., Henderson, N. C., Atkinson, K. M., Leffler, H., Nilsson, U. J., Haslett, C., Forbes, S. J., Sethi, T. (2008) Regulation of alternative macrophage activation by galectin-3. J. Immunol. 180, 2650-2658.
33. Jansen, A., Homo-Delarche, F., Hooijkaas, H., Leenen, P. J., Dardenne, M., Drexhage, H. A. (1994) Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and β-cell destruction in NOD mice. Diabetes 43, 667-675.
34. Fu, W., Wojtkiewicz, G., Weissleder, R., Benoist, C., Mathis, D. (2012) Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imaging. Nat. Immunol. 13, 361-368.
35. Brauner, H., Elemans, M., Lemos, S., Broberger, C., Holmberg, D., Flodström-Tullberg, M., Kärre, K., Höglund, P. (2010) Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice. J. Immunol. 184, 2272-2280.
36. Donath, M. Y., Shoelson, S. E. (2011) Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98-107.
37. Benoit, M., Desnues, B., Mege, J-L. (2008) Macrophage polarization in bacterial infections. J. Immunol. 181, 3733-3739.
38. Kristiansen, O. P., Mandrup-Poulsen, T. (2005) Interleukin-6 and diabetes. Diabetes 54, S114-S124.
39. Hawkins, T. A., Gala, R. R., Dunbar, J. C. (1996) The lymphocyte and macrophage profile in the pancreas and spleen of NOD mice: percentage of interleukin-2 and prolactin receptors on immunocompetent cell subsets. J. Reprod. Immunol. 32, 55-71.
40. Rocha, V. Z., Libby, P. (2009) Obesity, inflammation, and atherosclerosis. Nat. Rev. Cardiol. 6, 399-409.
41. Yin, N., Zhang, N., Lal, G., Xu, J., Yan, M., Ding, Y., Bromberg, J. S. (2011) Lymphangiogenesis is required for pancreatic islet inflammation and diabetes. PLoS One 6, e28023.
42. Stein, M., Keshav, S., Harris, N., Gordon, S. (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287-292.
43. Cameron, M. J., Arreaza, G. A., Grattan, M., Meagher, C., Sharif, S., Burdick, M. D., Strieter, R. M., Cook, D. N., Delovitch, T. L. (2000) Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes. J. Immunol. 165, 1102-1110.
44. Arnush, M., Heitmeier, M. R., Scarim, A. L., Marino, M. H., Manning, P. T., Corbett, J. A. (1998) IL-1 produced and released endogenously within human islets inhibits β cell function. J. Clin. Invest. 102, 516-526.
45. Liu, F-T., Rabinovich, G. A. (2010) Galectins: regulators of acute and chronic inflammation. Ann. N. Y. Acad. Sci. 1183, 158-182.
46. Novak, R., Dabelic, S., Dumic, J. (2012) Galectin-1 and galectin-3 expression profiles in classically and alternatively activated human macrophages. Biochim. Biophys. Acta 1820, 1383-1390.
47. Henderson, N. C., Sethi, T. (2009) The regulation of inflammation by galectin-3. Immunol. Rev. 230, 160-171.
48. Mahbub, S., Deburghgraeve, C. R., Kovacs, E. J. (2012) Advanced age impairs macrophage polarization. J. Interferon Cytokine Res. 32, 18-26.